View in EDS HTML Full Text PDF Full Text

Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease.

Saved in:
Bibliographic Details
Title: Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease.
Authors: Node K; Department of Cardiovascular Medicine, Saga University, Saga, Japan., Batterham RL; Eli Lilly and Company, Basingstoke, UK., Liu-Seifert H; Eli Lilly and Company, Indianapolis, IN, USA., Li R; Eli Lilly and Company, Indianapolis, IN, USA., Yoshino M; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Oura T; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Tanizawa Y; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Komuro I; Department of Frontier Cardiovascular Science, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; International University of Health and Welfare, Tokyo, Japan.
Source: Current medical research and opinion [Curr Med Res Opin] 2026 Apr; Vol. 42 (4), pp. 751-763. Date of Electronic Publication: 2026 Jun 13.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42287159
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Node+K%22">Node K</searchLink>; Department of Cardiovascular Medicine, Saga University, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Batterham+RL%22">Batterham RL</searchLink>; Eli Lilly and Company, Basingstoke, UK.<br /><searchLink fieldCode="AU" term="%22Liu-Seifert+H%22">Liu-Seifert H</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Li+R%22">Li R</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Yoshino+M%22">Yoshino M</searchLink>; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Oura+T%22">Oura T</searchLink>; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Tanizawa+Y%22">Tanizawa Y</searchLink>; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Komuro+I%22">Komuro I</searchLink>; Department of Frontier Cardiovascular Science, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; International University of Health and Welfare, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220351014%22">Current medical research and opinion</searchLink> [Curr Med Res Opin] 2026 Apr; Vol. 42 (4), pp. 751-763. <i>Date of Electronic Publication: </i>2026 Jun 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0351014 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1473-4877 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203007995%22">03007995 </searchLink><i>NLM ISO Abbreviation: </i>Curr Med Res Opin <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42287159
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/03007995.2026.2686052
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 751
    Titles:
      – TitleFull: Post hoc analysis of SURMOUNT-J: tirzepatide versus placebo and predicted 10-year cardiovascular disease risk in Japanese adults with obesity disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Node K
      – PersonEntity:
          Name:
            NameFull: Batterham RL
      – PersonEntity:
          Name:
            NameFull: Liu-Seifert H
      – PersonEntity:
          Name:
            NameFull: Li R
      – PersonEntity:
          Name:
            NameFull: Yoshino M
      – PersonEntity:
          Name:
            NameFull: Oura T
      – PersonEntity:
          Name:
            NameFull: Tanizawa Y
      – PersonEntity:
          Name:
            NameFull: Komuro I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1473-4877
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Current medical research and opinion
              Type: main
ResultId 1